Dyne Therapeutics, Inc.
DYN
$13.41
$0.141.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 677.49M | 642.27M | 723.67M | 778.84M | 453.55M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 12.01M | 17.01M | 12.72M | 13.48M | 34.59M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 689.50M | 659.28M | 736.39M | 792.32M | 488.14M |
|
|
|||||
| Total Current Assets | 689.50M | 659.28M | 736.39M | 792.32M | 488.14M |
| Net Property, Plant & Equipment | 29.63M | 30.01M | 30.52M | 31.64M | 32.22M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.94M | 1.94M | 1.94M | 1.93M | 1.92M |
| Total Assets | 721.07M | 691.23M | 768.84M | 825.88M | 522.28M |
|
|
|||||
| Total Accounts Payable | 7.02M | 6.56M | 6.16M | 1.89M | 7.21M |
| Total Accrued Expenses | 21.75M | 30.85M | 32.29M | 23.09M | 10.39M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.11M | 4.85M | 4.81M | 4.78M | 4.76M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 33.88M | 42.26M | 43.26M | 29.75M | 22.36M |
|
|
|||||
| Total Current Liabilities | 33.88M | 42.26M | 43.26M | 29.75M | 22.36M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 18.22M | 19.14M | 20.04M | 20.94M | 21.86M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 52.10M | 61.40M | 63.30M | 50.69M | 44.22M |
|
|
|||||
| Common Stock & APIC | 1.73B | 1.58B | 1.57B | 1.54B | 1.18B |
| Retained Earnings | -1.07B | -949.93M | -860.39M | -763.26M | -698.16M |
| Treasury Stock & Other | 241.00K | 6.00K | 478.00K | -240.00K | -132.00K |
| Total Common Equity | 668.97M | 629.84M | 705.54M | 775.19M | 478.06M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 668.97M | 629.84M | 705.54M | 775.19M | 478.06M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 668.97M | 629.84M | 705.54M | 775.19M | 478.06M |
|
|
|||||